The
findings reviewed by GME stated that the Global Laboratory Proficiency
Testing Market will expand with a CAGR value of 7.3 percent from
2021 to 2026. The market is expected to expand
during the forecast period due to key drivers such as the evolving biosimilars
market, rising demand for processed food items, and increased emphasis on water
treatment due to the presence of a wide variety of inorganic and organic
solutes, namely standard and toxic metals. Moreover, due to the increasing
emphasis on diagnostic laboratories because of the COVID-19 outbreak.
Browse 151 Market Data Tables and 111 Figures spread
through 181 Pages and in-depth TOC on “Global Laboratory Proficiency Testing Market Forecast to 2026"
By
Scope (Clinical Diagnostics, Pharmaceuticals, Microbiology, and Others), By
Technology (Cell Culture, Spectrometry, Polymerase Chain Reaction,
Chromatography, Immunoassays, and Others), By End-Use (Hospitals, Contract
Research Organizations, Pharmaceutical & Biotechnology Companies, Academic
Research, and Diagnostic Laboratories), By Region (North America, Asia Pacific,
CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market
Share Analysis & Competitor Analysis
Key Market Insights
·
Increasing
safety standards for the pharmaceutical and nutraceutical, as well as
increasing government awareness campaigns, are projected to spur the laboratory
proficiency testing market.
·
Clinical
diagnostics is leading in the scope segment, due to the surge in the populaces
of patients adopting timely and early diagnosis.
·
The
cell culture segment holds the highest sales volume share because this testing
has many benefits, including increased healthcare supply chain compliance,
efficiency, and reliability.
·
The
hospital is leading in the end-use segment, due to its widespread usage by
patients, hospitals, and doctors.
·
North
America is the market leader due to the rising public understanding of the
provision of high-quality laboratory proficiency testing programs.
·
Some
major participants competing in the global laboratory proficiency testing
market include College of
American Pathologists, LGC Limited,
American Proficiency Institute, BIPEA, Bio-Rad Laboratories, Inc., NSI Lab
Solutions, Merck & Co., Inc., Randox Laboratories Ltd., INSTAND, Weqas,
ERA, Absolute Standards, Inc., AOAC International, QACS - The Challenge Test
Laboratory, UK NEQAS, and RCPA.
Browse
the Report @ https://www.globalmarketestimates.com/market-report/global-laboratory-proficiency-testing-market-3055
Industry Scope Outlook (Revenue, USD Billion, 2021-2026)
· Clinical Diagnostics
·
Clinical Chemistry
·
Immunochemistry
·
Hematology
·
Oncology
·
Molecular Diagnostics
·
PCR
·
Others
·
Coagulation
· Pharmaceuticals
·
Biologics
·
Vaccines
·
Blood
·
Tissues
·
Others
· Microbiology
·
Pathogen Testing
·
Sterility Testing
·
Endotoxin & Pyrogen Testing
·
Growth Promotion Testing
·
Other Microbial Testing
· Others
Technology Outlook (Revenue, USD Billion, 2021-2026)
· Cell Culture
· Spectrometry
· Polymerase Chain
Reaction
· Chromatography
· Immunoassays
· Others
End-Use Outlook (Revenue, USD Billion, 2021-2026)
· Hospitals
· Contract Research
Organizations
· Pharmaceutical &
Biotechnology Companies
· Academic Research
· Diagnostic
Laboratories
·
Independent Laboratories
·
Specialty Laboratories
Regional Outlook
(Revenue, USD Billion, 2021-2026)
North America
- The
U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest
of Europe
Asia Pacific
- China
- India
- Japan
- South
Korea
- Australia
- Rest
of APAC
Central
& South America
- Brazil
- Argentina
- Rest
of CSA
Middle
East & Africa
- Saudi
Arabia
- UAE
- Rest
of MEA
Contact:
Tracy Simon
Email
address: tracy.simon@globalmarketestimates.com
Phone
Number: +16026667238
Website:
https://www.globalmarketestimates.com/
Check
our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php
